|
⚲
|
| Keyboard |
| Frazier Healthcare V LP
✚
|
|
|---|---|
| CIK # | 0001341169 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001341169] | |
| 4 | [0001341169] | |
| SC 13D | [0001341169] | |
| SC 13G | [0001341169] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Frazier Healthcare V LP | Anaptysbio Inc | [2017-02-10] |
| Frazier Healthcare V LP | Glaukos Corp | [2016-02-16] |
| Frazier Healthcare V LP | Tobira Therapeutics Inc | [2015-05-18] |
| Frazier Healthcare V LP | Zeltiq Aesthetics Inc | [2012-02-07] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Heron Patrick J | |
| FHM V LP | |
| Every Nathan R | |
| FHM V LLC | |
| Naini Nader J | |
| Frazier Alan D | |
| Frazier Healthcare V LP | |
| Anaptysbio Inc | |
| Regado Biosciences Inc | |
| Topper James N | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Anaptysbio Inc ANAB
Common Stock
|
2018-05-11 | Other | 1,372,000 | $0.00 | |
|
Anaptysbio Inc ANAB
Warrants · derivative
|
2017-02-02 | Option exercise | 117,235 | $0.00 | |
|
Anaptysbio Inc ANAB
Common Stock
|
2017-02-02 | Option exercise | 117,235 | $4.55 | 533,419 |
|
Anaptysbio Inc ANAB
Common Stock
|
2017-01-31 | Conversion | 1,428,571 | ||
|
Anaptysbio Inc ANAB
Common Stock
|
2017-01-31 | Conversion | 604,055 | ||
|
Anaptysbio Inc ANAB
Common Stock
|
2017-01-31 | Conversion | 195,751 | ||
|
Anaptysbio Inc ANAB
Common Stock
|
2017-01-31 | Conversion | 209,095 | ||
|
Anaptysbio Inc ANAB
Common Stock
|
2017-01-31 | Buy | 311,291 | $15.00 | 4,669,365 |
|
Anaptysbio Inc ANAB
Series D Preferred Stock · derivative
|
2017-01-31 | Conversion | 209,095 | $0.00 | |
|
Anaptysbio Inc ANAB
Series D Preferred Stock · derivative
|
2017-01-31 | Conversion | 733,740 | $0.00 | |
|
Anaptysbio Inc ANAB
Series B Preferred Stock · derivative
|
2017-01-31 | Conversion | 1,428,571 | $0.00 | |
|
Anaptysbio Inc ANAB
Series C-1 Preferred Stock · derivative
|
2017-01-31 | Conversion | 195,751 | $0.00 | |
|
Anaptysbio Inc ANAB
Series C Preferred Stock · derivative
|
2017-01-31 | Conversion | 604,055 | $0.00 | |
|
Anaptysbio Inc ANAB
Common Stock
|
2017-01-31 | Conversion | 733,740 | ||
|
Anaptysbio Inc ANAB
Common Stock
|
2017-01-31 | Buy | 88,709 | $15.00 | 1,330,635 |
|
Regado Biosciences Inc TBRA
Common Stock
|
2016-11-01 | Tender | 2,668,570 | $28.35 | 75,653,960 |
|
GLAUKOS Corp GKOS
Series D Convertible Preferred Stock · derivative
|
2015-06-30 | Conversion | 674,510 | $0.00 | |
|
GLAUKOS Corp GKOS
Series F Convertible Preferred Stock · derivative
|
2015-06-30 | Conversion | 253,390 | $0.00 | |
|
GLAUKOS Corp GKOS
Series E Convertible Preferred Stock · derivative
|
2015-06-30 | Conversion | 151,653 | $0.00 | |
|
GLAUKOS Corp GKOS
Common Stock
|
2015-06-30 | Conversion | 2,603,362 | ||
| showing 20 of 30 most recent transactions | |||||